Axsome Therapeutics (AXSM) received from FDA proposed labeling for AXS-05 product candidate with respect to its NDA for AXS-05 for treatment of major depressive disorder
Go back to Axsome Therapeutics (AXSM) received from FDA proposed labeling for AXS-05 product candidate with respect to its NDA for AXS-05 for treatment of major depressive disorder| (NASDAQ: AXSM) | Delayed: 71.10 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $71.10 | 52 Week High | $15.74 | |||
| Open | $71.10 | 52 Week Low | $5.37 | |||
| Day High | $71.10 | P/E | N/A | |||
| Day Low | $71.10 | EPS | $0.00 | |||
| Volume | 19 | |||||
